uridine diphosphate has been researched along with indomethacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, S; Matsumoto, T; Nakane, T | 1 |
| Erlinge, D; Hrafnkelsdóttir, T; Jern, S | 1 |
2 other study(ies) available for uridine diphosphate and indomethacin
| Article | Year |
|---|---|
UTP induces vascular responses in the isolated and perfused canine epicardial coronary artery via UTP-preferring P2Y receptors.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antinematodal Agents; Coronary Vessels; Diltiazem; Dogs; Female; Hexokinase; Indomethacin; Male; Protein Synthesis Inhibitors; Receptors, Purinergic P2; Saponins; Suramin; Triazines; Uridine Diphosphate; Uridine Triphosphate | 1997 |
Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man.
Topics: Adenosine Triphosphate; Adult; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Hemodynamics; Humans; Indomethacin; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Prostaglandin Antagonists; Tissue Plasminogen Activator; Uridine Diphosphate; Vasodilation | 2001 |